Nynke S van den Berg

7PUBLICATIONS
24CO-AUTHORS
Cancer diagnosisMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 05, 2022
89Zr-panitumumab Combined With 18F-FDG PET Improves Detection and Staging of Head and Neck Squamous Cell Carcinoma.

Yu-Jin Lee, Nynke S van den Berg, Heying Duan

|Nov 10, 2020
Co-administered antibody improves penetration of antibody-dye conjugate into human cancers with implications for antibody-drug conjugates.

Guolan Lu, Naoki Nishio, Nynke S van den Berg

|Jul 02, 2020
Comparison of Panitumumab-IRDye800CW and 5-Aminolevulinic Acid to Provide Optical Contrast in a Model of Glioblastoma Multiforme.

Tiara S Napier, Neha Udayakumar, Aditi H Jani

|Jan 26, 2020
Predicting Therapeutic Antibody Delivery into Human Head and Neck Cancers.

Guolan Lu, Shayan Fakurnejad, Brock A Martin

|Nov 08, 2019
Optical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancer.

Naoki Nishio, Nynke S van den Berg, Stan van Keulen

|May 31, 2019
The Sentinel Margin: Intraoperative Ex Vivo Specimen Mapping Using Relative Fluorescence Intensity.

Stan van Keulen, Naoki Nishio, Andrew Birkeland

Pageof 2

Frequent Collaborators

4 joint publications

Naoki Nishio

3 joint publications

Stan van Keulen

3 joint publications

Brock A Martin

2 joint publications

Eben L Rosenthal